RadNet, Inc. State and Local Income Tax Expense (Benefit), Continuing Operations
RadNet, Inc. (RDNT) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $4.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-02
- RadNet, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2025 was $4.04M, a 70.06% increase from fiscal 2024.
- RadNet, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2024 was $2.38M, a 31.00% decline from fiscal 2023.
- RadNet, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2023 was $3.44M, a 827.76% increase from fiscal 2022.
- RadNet, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2022 was $371.00K.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $4.04M 10-K · filed 2026-03-02 |
| 2024-12-31 | $2.38M 10-K · filed 2026-03-02 |
| 2023-12-31 | $3.44M 10-K · filed 2026-03-02 |
| 2022-12-31 | $371.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | -$2.19M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$1.61M 10-K · filed 2023-03-01 |
| 2019-12-31 | $7.71M 10-K · filed 2022-03-01 |
| 2018-12-31 | $7.26M 10-K · filed 2021-03-16 |
| 2017-12-31 | $4.91M 10-K · filed 2020-03-16 |
| 2016-12-31 | $914.00K 10-K · filed 2019-03-18 |
| 2015-12-31 | $1.71M 10-K · filed 2018-03-19 |
| 2014-12-31 | $1.28M 10-K · filed 2017-03-17 |
| 2013-12-31 | $643.00K 10-K · filed 2016-03-15 |
| 2012-12-31 | $1.16M 10-K · filed 2015-03-16 |
| 2011-12-31 | $820.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |